NCT05416970View on ClinicalTrials.gov

The Influence of SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver Disease Evolution

CompletedOBSERVATIONAL

Enrollment

122

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions

Non-Alcoholic Fatty Liver Disease

Interventions

BEHAVIORAL

SUPERIMPOSED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-CoV-2) LIFESTYLE CHANGES

To assess the impact of the SARS-CoV-2 spread related lifestyle changes on body composition analysis and metabolic syndrome components worsening as well as hepatocellular carcinoma occurrence.

Trial Locations (1)

80131

"University of Campania Luigi Vanvitelli", Naples

All Listed Sponsors

lead

University of Campania Luigi Vanvitelli

OTHER

NCT05416970 - The Influence of SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver Disease Evolution | Biotech Hunter | Biotech Hunter